Cutting-edge technology Elixirgen Therapeutics utilizes controllable self-replicating RNA technology, positioning it as an innovative player in the biotechnology sector with high potential for partnerships or collaborations.
Strategic location advantage Being situated in the Science + Technology Park at Johns Hopkins in Baltimore provides Elixirgen Therapeutics with proximity to top-tier research facilities, attracting researchers and potential investors looking to engage with cutting-edge advancements.
Funding background With a funding of $5M, Elixirgen Therapeutics has the financial support required for scaling operations and accelerating research and development initiatives, making it an attractive target for investment discussions or service providers.
Cross-sector collaboration potential Given Elixirgen's focus on developing therapies for rare diseases, aging-related disorders, and cancer, there is an opportunity for collaboration with healthcare providers, pharmaceutical companies, and research institutions aiming to expand their therapeutic offerings and treatment capabilities.
Market differentiation and potential Elixirgen stands out in a market characterized by companies of varying sizes and revenue figures, showcasing potential for growth and differentiation that could attract interest from investors, partners, and customers seeking novel solutions in biotechnology research.
36
25
482
$50M$100M
6.1K$1B
555$50M$100M
21$10M$50M
11$10MElixirgen Therapeutics, Inc. uses 8 technology products and services including Google Analytics, WordPress, MySQL, and more. Explore Elixirgen Therapeutics, Inc.'s tech stack below.
| Elixirgen Therapeutics, Inc. Email Formats | Percentage |
| Last.First@elixirgentherapeutics.com | 94% |
| First@elixirgentherapeutics.com | 6% |
| FLast@elixirgentx.com | 100% |
Biotechnology ResearchMaryland, United States11-50 Employees
Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.
Company Overview
Funding & FinancialsElixirgen Therapeutics, Inc. has raised a total of $5M of funding over 4 rounds. Their latest funding round was raised on Sep 28, 2022 in the amount of $5M.
Funding & FinancialsElixirgen Therapeutics, Inc. has raised a total of $5M of funding over 4 rounds. Their latest funding round was raised on Sep 28, 2022 in the amount of $5M.
1-888-653-2347 
support@leadiq.com